Volume 76, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


This case describes the investigation of a man from a country with high endemicity for human immunodeficiency virus (HIV) who was found to have co-infections with implications for management.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Thio CL, Seaberg EC, Skolasky R, Phair J, Visscsher B, 2002. Munoz and Thomas DL. HIV-1, hepatitis B virus, and the risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360 : 1921–1926.
    [Google Scholar]
  2. Dore GJ, Cooper DA, Pozniak AL, DeJesus E, Zhong L, Miller MD, Lu B, Cheng AK, 903 Study Team, 2004. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus. J Infect Dis 189 : 1185–1192.
    [Google Scholar]
  3. Bentwich Z, Maartens G, Torten D, Lal AA, Lal RB, 2000. Concurrent infections and HIV pathogenesis. AIDS 14 : 2071–2081.
    [Google Scholar]
  4. Gann P, Neva FA, Gam AA, 1994. A randomized trial of single-and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 169 : 1076–1079.
    [Google Scholar]
  5. Kaiser PB, Nutman TB, 2004. Strongyloides stercoralis in the immunocompromised population. Clin Micro Rev 17 : 208–217.
    [Google Scholar]

Data & Media loading...

  • Received : 19 Oct 2005
  • Accepted : 13 Jul 2006
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error